Insider Actions for Bio-Techne Corp.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 02/16/2021 |
Charles R. Kummeth Chief Executive Officer; Director |
17,428 | Derivative/Non-derivative trans. at $411 per share. | 7,162,908 |
| 02/16/2021 |
Charles R. Kummeth Chief Executive Officer; Director |
30,000 | Derivative/Non-derivative trans. at $94.35 per share. | 2,830,500 |
| 02/12/2021 |
James T. Hippel Chief Financial Officer |
600 | Disposition at $401.52 per share. | 240,912 |
| 02/12/2021 |
James T. Hippel Chief Financial Officer |
9,400 | Disposition at $400.32 per share. | 3,763,008 |
| 02/12/2021 |
Brenda Swierenga Furlow SVP - General Counsel |
3,326 | Disposition at $399.12 per share. | 1,327,473 |
| 02/12/2021 |
Brenda Swierenga Furlow SVP - General Counsel |
6,674 | Disposition at $398.4 per share. | 2,658,921 |
| 02/12/2021 |
James T. Hippel Chief Financial Officer |
10,000 | Derivative/Non-derivative trans. at $106.59 per share. | 1,065,900 |
| 02/12/2021 |
Brenda Swierenga Furlow SVP - General Counsel |
10,000 | Derivative/Non-derivative trans. at $106.59 per share. | 1,065,900 |
| 02/08/2021 |
Roeland Nusse Director |
6,000 | Disposition at $385.08 per share. | 2,310,480 |
| 02/08/2021 |
Roeland Nusse Director |
5,000 | Derivative/Non-derivative trans. at $66.9 per share. | 334,500 |
| 02/08/2021 |
Roeland Nusse Director |
1,000 | Derivative/Non-derivative trans. at $70.35 per share. | 70,350 |
| 02/05/2021 |
Norman David Eansor President-Protein Sciences |
1,100 | Disposition at $385.59 per share. | 424,149 |
| 02/05/2021 |
Norman David Eansor President-Protein Sciences |
1,900 | Disposition at $384.15 per share. | 729,885 |
| 02/05/2021 |
Norman David Eansor President-Protein Sciences |
3,700 | Disposition at $382.6 per share. | 1,415,620 |
| 02/05/2021 |
Norman David Eansor President-Protein Sciences |
2,900 | Disposition at $381.52 per share. | 1,106,408 |
| 02/05/2021 |
Norman David Eansor President-Protein Sciences |
12,833 | Disposition at $380.5 per share. | 4,882,956 |
| 02/05/2021 |
Norman David Eansor President-Protein Sciences |
4,500 | Disposition at $379.62 per share. | 1,708,290 |
| 02/05/2021 |
Norman David Eansor President-Protein Sciences |
6,000 | Disposition at $378.29 per share. | 2,269,740 |
| 02/05/2021 |
Kim Kelderman Pres. Diagnostics & Genom |
823 | Disposition at $388.45 per share. | 319,694 |
| 02/05/2021 |
Norman David Eansor President-Protein Sciences |
18,819 | Derivative/Non-derivative trans. at $106.59 per share. | 2,005,917 |
| 02/05/2021 |
Norman David Eansor President-Protein Sciences |
14,114 | Derivative/Non-derivative trans. at $106.59 per share. | 1,504,411 |
| 01/15/2021 |
Charles R. Kummeth Chief Executive Officer; Director |
20,000 | Disposition at $344 per share. | 6,880,000 |
| 01/11/2021 |
James T. Hippel Chief Financial Officer |
2,009 | Disposition at $334.98 per share. | 672,974 |
| 01/11/2021 |
James T. Hippel Chief Financial Officer |
3,990 | Disposition at $334.39 per share. | 1,334,216 |
| 01/11/2021 |
James T. Hippel Chief Financial Officer |
2,501 | Disposition at $333.23 per share. | 833,408 |
| 01/11/2021 |
James T. Hippel Chief Financial Officer |
700 | Disposition at $331.61 per share. | 232,127 |
| 01/11/2021 |
James T. Hippel Chief Financial Officer |
400 | Disposition at $330.26 per share. | 132,104 |
| 01/11/2021 |
James T. Hippel Chief Financial Officer |
400 | Disposition at $328.68 per share. | 131,472 |
| 01/11/2021 |
James T. Hippel Chief Financial Officer |
10,000 | Derivative/Non-derivative trans. at $106.59 per share. | 1,065,900 |
| 12/07/2020 |
Charles R. Kummeth Chief Executive Officer; Director |
5,000 | Disposition at $308 per share. | 1,540,000 |
| 11/30/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
707 | Disposition at $302.82 per share. | 214,093 |
| 11/30/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
6,783 | Disposition at $302.15 per share. | 2,049,483 |
| 11/30/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
3,367 | Disposition at $301.32 per share. | 1,014,544 |
| 11/30/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
938 | Derivative/Non-derivative trans. at $106.59 per share. | 99,981 |
| 11/30/2020 |
Brenda Swierenga Furlow SVP - General Counsel |
10,857 | Derivative/Non-derivative trans. at $106.59 per share. | 1,157,247 |
| 11/18/2020 |
Robert V. Baumgartner Director |
5,000 | Disposition at $303.34 per share. | 1,516,700 |
| 11/18/2020 |
Robert V. Baumgartner Director |
5,000 | Derivative/Non-derivative trans. at $66.9 per share. | 334,500 |
| 11/11/2020 |
James T. Hippel Chief Financial Officer |
1,100 | Disposition at $307.78 per share. | 338,558 |
| 11/11/2020 |
James T. Hippel Chief Financial Officer |
6,291 | Disposition at $306.93 per share. | 1,930,896 |
| 11/11/2020 |
James T. Hippel Chief Financial Officer |
7,391 | Derivative/Non-derivative trans. at $106.59 per share. | 787,806 |
